In the treatment of glaucoma, the ability of continuous-wave (CW) transscleral laser photocoagulation (TSCPC) to lower intraocular pressure (IOP) must be weighed against its established risks.

Please provide your email address to receive an email when new articles are posted on . The phase 3 BUTTERFLEYE trial compared aflibercept vs. laser photocoagulation in infants with retinopathy of ...

Please provide your email address to receive an email when new articles are posted on . SEATTLE —There was no significant difference in cognitive outcomes for patients with retinopathy of prematurity ...

SAN FRANCISCO — Retinopathy of prematurity seems to respond equally to either an injection with aflibercept or laser photocoagulation when infants who were treated reached age 2 years, according to ...

The BUTTERFLEYE trial sought to determine if aflibercept, an anti–vascular endothelial growth factor (anti-VEGF) therapy, was equivalent to laser photocoagulation, the gold standard to treat ...

Why did a 38-year-old woman with neurofibromatosis type 1 (NF1) develop choroidal Yasunari nodules in both eyes? That's what Danish clinicians had to figure out when the patient presented for a ...

Oral vascular lesions, encompassing a range of benign anomalies such as venous lakes and haemangiomas, represent both functional and cosmetic challenges for affected individuals. Advances in laser ...

No, diabetes-related retinopathy is not reversible. But you can slow down progression or stop it from getting worse through diabetes management, eye injections, laser treatment, and more. Diabetic ...